Silo Pharma (SILO) Enterprise Value (2010 - 2026)
Silo Pharma (SILO) posted Enterprise Value of -$6.0 million for Q1 2026, up 12.05% sequentially from -$6.9 million in Q4 2025, and down 10.65% YoY from -$6.8 million in Q1 2025.
Silo Pharma (SILO) Enterprise Value (2010 - 2026) Analysis & Trends
Silo Pharma has reported Enterprise Value for 14 years, with the latest figure at -$6.0 million in Q1 2026.
- Quarterly Enterprise Value fell 10.65% year-over-year to -$6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.0 million (down 10.65% YoY) and the FY2025 annual result came in at -$6.9 million, up 3.13% from the prior year.
- Enterprise Value advanced to -$6.0 million in Q1 2026 per SILO's latest filing, from -$6.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$5.5 million in Q1 2025 and troughed at -$12.3 million in Q3 2022.
- A 5-year average of -$8.1 million and a median of -$7.7 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value sank 110.42% in 2022, then jumped 36.85% in 2024.
- Over 5 years, Enterprise Value stood at -$11.4 million in 2022, then surged by 32.58% to -$7.7 million in 2023, then rose by 7.63% to -$7.1 million in 2024, then climbed by 3.13% to -$6.9 million in 2025, then climbed by 12.05% to -$6.0 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$6.0 million, -$6.9 million, and -$5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 2.12 Bn |
| 10 | Silo Pharma | 2.93 Mn | 2.93 Mn | - | -5.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.23 Mn |
| Mar 31, 2026 | -6.03 Mn |
| Dec 31, 2025 | -6.86 Mn |
| Sep 30, 2025 | -5.87 Mn |
| Jun 30, 2025 | -6.26 Mn |
| Mar 31, 2025 | -5.45 Mn |
| Dec 31, 2024 | -7.08 Mn |
| Sep 30, 2024 | -8.02 Mn |
| Jun 30, 2024 | -7.61 Mn |
| Mar 31, 2024 | -6.74 Mn |
| Dec 31, 2023 | -7.67 Mn |
| Sep 30, 2023 | -8.77 Mn |
| Jun 30, 2023 | -9.99 Mn |
| Mar 31, 2023 | -10.68 Mn |
| Dec 31, 2022 | -11.37 Mn |
| Sep 30, 2022 | -12.25 Mn |
| Jun 30, 2022 | -8.73 Mn |
| Mar 31, 2022 | -9.07 Mn |
| Dec 31, 2021 | -10.26 Mn |
| Sep 30, 2021 | -10.26 Mn |